1.19
+0.14(+13.33%)
Currency In USD
| Previous Close | 1.05 |
| Open | 1.03 |
| Day High | 1.19 |
| Day Low | 1.02 |
| 52-Week High | 6.57 |
| 52-Week Low | 0.87 |
| Volume | 1.51M |
| Average Volume | 1.89M |
| Market Cap | 70.8M |
| PE | -0.53 |
| EPS | -2.25 |
| Moving Average 50 Days | 1.49 |
| Moving Average 200 Days | 1.91 |
| Change | 0.14 |
If you invested $1000 in Biomea Fusion, Inc. (BMEA) since IPO date, it would be worth $63.98 as of December 05, 2025 at a share price of $1.19. Whereas If you bought $1000 worth of Biomea Fusion, Inc. (BMEA) shares 3 years ago, it would be worth $175.78 as of December 05, 2025 at a share price of $1.19.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
GlobeNewswire Inc.
Dec 01, 2025 9:10 PM GMT
SAN CARLOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it has been selected for an oral presentati
Biomea Fusion to Participate at Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 24, 2025 12:00 PM GMT
SAN CARLOS, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in the upcoming investo
Biomea Fusion to Participate at Jefferies London Healthcare Conference
GlobeNewswire Inc.
Nov 10, 2025 12:00 PM GMT
SAN CARLOS, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it is scheduled to participate in a firesid